By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RedHill Biopharma Ltd. 

21 Ha’arba’a Street

Tel-Aviv    64739  Israel
Phone: 972-0-3-541-3131 Fax: 972-0-3-541-3144



Company News
RedHill Biopharma Ltd. (RDHL) Reports Results For The Third Quarter Of 2014 11/10/2014 7:51:48 AM
FDA Grants QIDP Fast-Track Designation To RedHill Biopharma Ltd. (RDHL)'s Phase 3 H. Pylori Drug RHB-105 11/10/2014 7:32:47 AM
RedHill Biopharma Ltd. (RDHL) To Host Third Quarter 2014 Financial Results Conference Call On November 10, 2014 10/28/2014 7:02:57 AM
RedHill Biopharma Ltd. (RDHL) To Present At The 20th Annual BIO-Europe International Partnering Conference 10/22/2014 7:30:24 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Submit European Marketing Authorization Application For Migraine Drug RIZAPORT® (Formerly RHB-103) 10/1/2014 9:12:10 AM
RedHill Biopharma Ltd. (RDHL) To Present At The 14th Annual Biotech In Europe Forum For Global Partnering & Investment 9/16/2014 1:11:19 PM
RedHill Biopharma Ltd. (RDHL) To Present At The 7th Annual Biopharm America International Partnering Conference 9/15/2014 7:57:08 AM
RedHill Biopharma Ltd. (RDHL) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/5/2014 7:44:58 AM
RedHill Biopharma Ltd. (RDHL) Initiates Phase 3 Study Of RHB-102 For Gastroenteritis 9/3/2014 7:16:00 AM
RedHill Biopharma Ltd. (RDHL) Provides Update On Expansion Of Ongoing RHB-105 Phase 3 Study, Targeting Broadened H. Pylori Indication Authorized By FDA 8/27/2014 7:45:56 AM